Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Omega-3 fatty acids for bipolar disorder
Your Article Summary
See Latest ArticlesAntipsychotic prescribing trends: a review of pharmaco-epidemiological studies
Acta Psychiatrica Scandinavica, 06/30/09
Verdoux H et al. - Considering the growing number of persons from the general population exposed to APs, population studies assessing the risk/benefit ratio of SGAP use in disorders other than psychosis are necessary, particularly in children and adolescents.
Methods- Retrieved original studies that explored AP prescribing trends in general population samples since 2000.
- For each study, we extracted information on sampling method, period, assessment of AP use and corresponding estimates (incidence rates, prevalence rates, pharmacy sales, prescription data) and diagnostic assessment.
- Nearly all studies meeting the inclusion criteria (n = 17) showed an increase in AP prescriptions, mainly because of a dramatic rise in second-generation antipsychotics (SGAP) prescriptions.
- APs are often prescribed for non-psychotic disorders in adults as well as in children and adolescents.
Related Articles
Total cholesterol and LDL levels decrease before rheumatoid arthritis
Annals of Rheumatic Diseases, 11/10/09
Relevance Score: 87%
Peripheral Arterial Disease: Current Perspectives and New Trends in Management
Southern Medical Journal, 11/10/09
Relevance Score: 79%
Antipsychotic effects on auditory sensory gating in schizophrenia patients
European Neuropsychopharmacology, 10/21/09
Relevance Score: 79%
Large scale questionnaire survey on respiratory health in Sweden: Effects of late- and non-response
Respiratory Medicine, 11/11/09
Relevance Score: 78%
Is there a declining trend in ovarian function among infertility clinic patients
Human Reproduction, 10/29/09
Relevance Score: 78%
Today in Neuro/Psych Pharmacol...keeping you current
Receive free subspecialty "5-minute updates" via email
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Schizophrenia Bulletin, 11/30/09
Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance
International Journal of Geriatric Psychiatry, 11/30/09
Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia
Human Psychopharmacology: Clinical and Experimental, 11/30/09
Today in Other Psychiatry...keeping you current
Receive free subspecialty "5-minute updates" via email
Do Treatment Improvements in PTSD Severity Affect Substance Use Outcomes? A Secondary Analysis From a Randomized Clinical Trial in NIDAs Clinical Trials Network
American Journal of Psychiatry, 11/30/09
Group Psychotherapy of Dysfunctional Fear of Progression in Patients with Chronic Arthritis or Cancer
Psychotherapy and Psychosomatics, 11/30/09
The trauma of psychosis: Posttraumatic stress disorder and recent onset psychosis
Schizophrenia Research, 11/30/09
Today in Schizophrenia/Psychosis...keeping you current
Receive free subspecialty "5-minute updates" via email
The trauma of psychosis: Posttraumatic stress disorder and recent onset psychosis
Schizophrenia Research, 11/30/09
Low Dose vs Standard Dose of Antipsychotics for Relapse Prevention in Schizophrenia: Meta-analysis
Schizophrenia Bulletin, 11/30/09
Augmentation of atypical antipsychotics with valproic acid. An open-label study for most difficult patients with schizophrenia
Human Psychopharmacology: Clinical and Experimental, 11/30/09
Sponsor
Article Search
Sponsor